ErbB-directed immunotherapy: antibodies in current practice and promising new agents

Immunology Letters
Elza FriedländerGyörgy Vereb

Abstract

The ErbB family is well known for its significance in oncogenesis. As bad prognostic markers, overexpressed or mutated ErbB1 and ErbB2 have an important role in the molecular diagnosis of various cancers, but as membrane proteins, expressed often selectively in tumor tissues, they can be targeted with kinase inhibitors or therapeutic antibodies. In addition to trastuzumab, the first humanized antibody that was approved for the therapy of solid tumors by the FDA, now many humanized antibodies are in late clinical trials, or already approved. Conjugation of antibodies with radioactive isotopes, cytotoxic agents or liposomes loaded with chemotherapeutic drugs led to improved therapeutic efficiency over their parent "unarmed" antibodies. Novel, engineered antibody derivates with better pharmacodynamic properties are also available and allow the targeting of ErbB1 or ErbB2 positive cancers in a wider patient population. In this review, we discuss the biological and clinical background of ErbB targeting, and describe the most successful antibodies against ErbB1 (cetuximab, panitumumab, matuzumab, nimotuzumab, ICR62, mAb 528, ch806 and MDX-447) and ErbB2 (trastuzumab, pertuzumab, MDX-H210, 2B1, C6.5xscFv(NM3E2), ertumaxomab and FRP-5 ...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P CarterH M Shepard
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·I StancovskiM Sela
Mar 15, 1990·International Journal of Cancer. Journal International Du Cancer·P G NataliA Ullrich
Nov 15, 1995·International Journal of Cancer. Journal International Du Cancer·D HillsW J Gullick
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·E HurwitzY Yarden
Dec 1, 1993·British Journal of Cancer·I M HarwerthN E Hynes
Aug 18, 1993·Journal of the National Cancer Institute·J BaselgaJ Mendelsohn
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·S ParangiD Hanahan
Jan 22, 1998·Cancer Immunology, Immunotherapy : CII·R T Curnow
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Aug 15, 2000·The Journal of Biological Chemistry·G LevkowitzY Yarden
Aug 31, 2000·Annual Review of Biochemistry·S R Hubbard, J H Till
Sep 6, 2000·The EMBO Journal·K M FergusonM A Lemmon
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Mar 20, 2001·Critical Reviews in Oncology/hematology·X D YangC G Davis
Apr 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y L YipR L Ward
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·J W ParkC C Benz
Aug 28, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Baselga, J Albanell

❮ Previous
Next ❯

Citations

Nov 3, 2012·Protein Engineering, Design & Selection : PEDS·Takeshi NakanishiIzumi Kumagai
Apr 16, 2009·Clinical Microbiology Reviews·Edsel Maurice T Salvana, Robert A Salata
Jun 16, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Gabriela Kramer-MarekJacek Capala
Jul 11, 2013·Future Oncology·Vidyalakshmi ChandramohanDarell D Bigner
May 24, 2013·Carcinogenesis·Malgorzata Magdalena SakEspen Stang
Dec 18, 2008·Journal of Drug Targeting·Max KullbergJesse Lee Owens
Jun 26, 2009·Trends in Pharmacological Sciences·Royston Jefferis
Nov 15, 2008·Cancer Treatment Reviews·Dorte Lisbet NielsenClaus Kamby
Nov 11, 2008·Experimental Cell Research·Karl R Schmitz, Kathryn M Ferguson
Jan 26, 2011·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Márk Barok, János Szollosi
Aug 13, 2013·Molecular and Cellular Endocrinology·Carlo PalmieriSacha J Howell
Oct 12, 2010·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Ákos I FábiánAttila Jenei
Sep 26, 2017·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Gábor TóthGyörgy Vereb
Jul 19, 2016·Expert Review of Proteomics·Rebecca Christine Feiner, Kristian Mark Müller
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vincenzo DamianoGiampaolo Tortora
Dec 19, 2020·International Journal of Molecular Sciences·Rebecca C FeinerKristian M Müller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.